These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 37666951

  • 1. Identification of m5C-related lncRNAs signature to predict prognosis and therapeutic responses in esophageal squamous cell carcinoma patients.
    Ma Y, Sun Y, Zhao X, Li J, Fu X, Gong T, Zhang X.
    Sci Rep; 2023 Sep 04; 13(1):14499. PubMed ID: 37666951
    [Abstract] [Full Text] [Related]

  • 2. Novel chemokine related LncRNA signature correlates with the prognosis, immune landscape, and therapeutic sensitivity of esophageal squamous cell cancer.
    Zhang Z, Wang J, Han W, Zhao L.
    BMC Gastroenterol; 2023 Apr 20; 23(1):132. PubMed ID: 37081402
    [Abstract] [Full Text] [Related]

  • 3. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.
    Li W, Liu J, Zhao H.
    Aging (Albany NY); 2020 Jan 24; 12(2):1512-1526. PubMed ID: 31978896
    [Abstract] [Full Text] [Related]

  • 4. The prognostic value of a seven-lncRNA signature in patients with esophageal squamous cell carcinoma: a lncRNA expression analysis.
    Weng NQ, Chi J, Wen J, Mai SJ, Zhang MY, Huang L, Liu J, Yang XZ, Xu GL, Fu JH, Wang HY.
    J Transl Med; 2020 Jan 31; 18(1):47. PubMed ID: 32005248
    [Abstract] [Full Text] [Related]

  • 5. Identification and validation of an autophagy-related gene signature for predicting prognosis in patients with esophageal squamous cell carcinoma.
    Shi X, Li Y, Pan S, Liu X, Ke Y, Guo W, Wang Y, Ruan Q, Zhang X, Ma H.
    Sci Rep; 2022 Feb 04; 12(1):1960. PubMed ID: 35121801
    [Abstract] [Full Text] [Related]

  • 6. A fibroblast-associated signature predicts prognosis and immunotherapy in esophageal squamous cell cancer.
    Ren Q, Zhang P, Zhang X, Feng Y, Li L, Lin H, Yu Y.
    Front Immunol; 2023 Feb 04; 14():1199040. PubMed ID: 37313409
    [Abstract] [Full Text] [Related]

  • 7. Identification and validation of an eight-lncRNA signature that predicts prognosis in patients with esophageal squamous cell carcinoma.
    Zhang J, Ling X, Fang C, Ma J.
    Cell Mol Biol Lett; 2022 May 16; 27(1):39. PubMed ID: 35578166
    [Abstract] [Full Text] [Related]

  • 8. Exploring the Potential of Exosome-Related LncRNA Pairs as Predictors for Immune Microenvironment, Survival Outcome, and Microbiotain Landscape in Esophageal Squamous Cell Carcinoma.
    Zhao F, Li Z, Dong Z, Wang Z, Guo P, Zhang D, Li S.
    Front Immunol; 2022 May 16; 13():918154. PubMed ID: 35880180
    [Abstract] [Full Text] [Related]

  • 9. Identification of m6A/m5C-related lncRNA signature for prediction of prognosis and immunotherapy efficacy in esophageal squamous cell carcinoma.
    Wang J, Ren H, Xu C, Yu B, Cai Y, Wang J, Ni X.
    Sci Rep; 2024 Apr 08; 14(1):8238. PubMed ID: 38589454
    [Abstract] [Full Text] [Related]

  • 10. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W, Tan F, Huai Q, Wang Z, Shao F, Zhang G, Yang Z, Li R, Xue Q, Gao S, He J.
    Front Immunol; 2021 Apr 08; 12():669750. PubMed ID: 34054840
    [Abstract] [Full Text] [Related]

  • 11. A tumor immune microenvironment-related integrated signature can predict the pathological response and prognosis of esophageal squamous cell carcinoma following neoadjuvant chemoradiotherapy: A multicenter study in China.
    Wu P, Zhang Z, Yuan Y, Zhang C, Zhang G, Xue L, Yang H, Wang L, Zheng X, Zhang Y, Yuan Y, Lei R, Yang Z, Zheng B, Xue Q, Sun N, He J.
    Int J Surg; 2022 Nov 08; 107():106960. PubMed ID: 36257585
    [Abstract] [Full Text] [Related]

  • 12. Upregulation of long noncoding RNA LEF1-AS1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma.
    Zong MZ, Feng WT, Du N, Yu XJ, Yu WY.
    Eur Rev Med Pharmacol Sci; 2019 Sep 08; 23(18):7929-7934. PubMed ID: 31599448
    [Abstract] [Full Text] [Related]

  • 13. A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma.
    Huang GW, Xue YJ, Wu ZY, Xu XE, Wu JY, Cao HH, Zhu Y, He JZ, Li CQ, Li EM, Xu LY.
    BMC Cancer; 2018 Feb 06; 18(1):147. PubMed ID: 29409459
    [Abstract] [Full Text] [Related]

  • 14. Integrated analysis highlights multiple long non‑coding RNAs and their potential roles in the progression of human esophageal squamous cell carcinoma.
    Li CY, Zhang WW, Xiang JL, Wang XH, Wang JL, Li J.
    Oncol Rep; 2019 Dec 06; 42(6):2583-2599. PubMed ID: 31638253
    [Abstract] [Full Text] [Related]

  • 15. A novel immune-related radioresistant lncRNAs signature based model for risk stratification and prognosis prediction in esophageal squamous cell carcinoma.
    Zheng J, Chen X, Huang B, Li J.
    Front Genet; 2022 Dec 06; 13():921902. PubMed ID: 36147506
    [Abstract] [Full Text] [Related]

  • 16. A RASSF8-AS1 based exosomal lncRNAs panel used for diagnostic and prognostic biomarkers for esophageal squamous cell carcinoma.
    Xie K, Zheng C, Gu W, Jiang Z, Luo C, Luo J, Diao Y, Wang G, Cong Z, Yao X, Hu L, Shen Y.
    Thorac Cancer; 2022 Dec 06; 13(23):3341-3352. PubMed ID: 36266257
    [Abstract] [Full Text] [Related]

  • 17. Transcriptome profiling of lncRNA and co-expression networks in esophageal squamous cell carcinoma by RNA sequencing.
    Li Y, Shi X, Yang W, Lu Z, Wang P, Chen Z, He J.
    Tumour Biol; 2016 Oct 06; 37(10):13091-13100. PubMed ID: 27449043
    [Abstract] [Full Text] [Related]

  • 18. Prognostic value and immune landscapes of cuproptosis-related lncRNAs in esophageal squamous cell carcinoma.
    Zhang X, Feng N, Wu B, Guo Z, Pan T, Tao X, Zheng H, Zhang W.
    Aging (Albany NY); 2023 Oct 06; 15(19):10473-10500. PubMed ID: 37812189
    [Abstract] [Full Text] [Related]

  • 19. Ferroptosis-Related lncRNA Signature Correlates with the Prognosis, Tumor Microenvironment, and Therapeutic Sensitivity of Esophageal Squamous Cell Carcinoma.
    Zhu J, Zhao Y, Wu G, Zhang X, Chen Q, Yang B, Guo X, Ji S, Gu K.
    Oxid Med Cell Longev; 2022 Oct 06; 2022():7465880. PubMed ID: 35903713
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.